CHRNA7 and non-small cell lung carcinoma: Thus, we reported that dupα7 overexpression inhibits, both in vitro and in vivo, α7-nAChR-mediated protumorigenic activity in human cell lines from non-small-cell lung cancer (NSCLC) (38).